Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Enfermedad hepática esteatótica asociada a la disfunción metabólica: un conductor silencioso del riesgo cardiovascular y un nuevo objetivo de intervención

  • 0Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Via di Grottarossa 1035-1039, 00189 Rome, Italy.

|

|

Resumen

Este resumen es generado por máquina.

La enfermedad hepática estatotica asociada a la disfunción metabólica (MASLD, por sus siglas en inglés) está relacionada con problemas cardíacos graves y otros problemas de salud. El diagnóstico y el tratamiento tempranos pueden retrasar la progresión de la enfermedad y reducir el riesgo cardiovascular.

Área De La Ciencia

  • Hepatología
  • Cardiología
  • Enfermedades metabólicas

Sus Antecedentes

  • La enfermedad hepática estatotica asociada a la disfunción metabólica (MASLD, por sus siglas en inglés) es un problema de salud creciente.
  • MASLD eleva significativamente el riesgo de esteatohepatitis, cirrosis y complicaciones extrahepáticas como la enfermedad cardiometabólica.
  • Los eventos cardiovasculares son la principal causa de mortalidad en los pacientes con MASLD.

Objetivo Del Estudio

  • Revisar la comprensión actual de la enfermedad y la fisiopatología de la esteatohepatitis asociada a la disfunción metabólica (MASH).
  • Hacer hincapié en el impacto sistémico de MASLD/MASH, en particular su relación con las enfermedades cardiovasculares (ECV).
  • Discutir las estrategias de tratamiento actuales y emergentes para MASLD y MASH.

Principales Métodos

  • Esto es una revisión narrativa.
  • La revisión sintetiza los conocimientos existentes sobre el MASLD y el MASH.
  • Se centra en la fisiopatología, los efectos sistémicos, los vínculos CVD y los tratamientos.

Principales Resultados

  • MASLD es una enfermedad sistémica con implicaciones cardiometabólicas significativas.
  • Las enfermedades cardiovasculares son una de las principales causas de muerte en pacientes con MASLD.
  • El diagnóstico y la gestión oportunos son cruciales para mitigar los riesgos.

Conclusiones

  • El MASLD y el MASH requieren un enfoque integral debido a su naturaleza sistémica.
  • Comprender la fisiopatología es clave para desarrollar tratamientos efectivos.
  • Las intervenciones dirigidas al estilo de vida y a los factores metabólicos pueden reducir la progresión de la enfermedad y el riesgo cardiovascular.

Videos de Conceptos Relacionados

Overview of Lipid Metabolism 01:24

2.4K

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Coronary Artery Disease I: Introduction 01:30

54

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Atherosclerosis III: Management 01:26

33

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents 01:20

865

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cholesterol: Significance and Regulation 01:29

669

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Liver Physiology 01:30

1.1K

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...